Skip to Content

TARO 16 (Carbamazepine (chewable) 100 mg)

Pill imprint TARO 16 has been identified as Carbamazepine (chewable) 100 mg.

Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; epilepsy; schizoaffective disorder; diabetic peripheral neuropathy (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 100 mg is not subject to the Controlled Substances Act.

See also related documents.

Carbamazepine (chewable) 100 mg TARO 16
Carbamazepine (chewable) 100 mg TARO 16  Front
Carbamazepine (chewable) 100 mg TARO 16  Back
Carbamazepine (chewable) 100 mg TARO 16
Carbamazepine (chewable)
100 mg
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Taro Pharmaceuticals U.S.A., Inc.
National Drug Code (NDC):
Inactive Ingredients:
croscarmellose sodium
diethyl phthalate
FD&C Red No. 40
aluminum oxide
magnesium stearate
microcrystalline cellulose
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
62584-0639 Amerisource Health Services
58016-0501 Southwood Pharmaceuticals Inc (repackager)
49999-0782 Lake Erie Medical and Surgical Supply (repackager)
54569-2795 A-S Medication Solutions, LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.